5-氨基乙酰丙酸荧光引导立体定向脑肿瘤活检中术中病理的必要性
本研究纳入79例疑似脑肿瘤患者,在立体定向活检前给予5-ALA,强荧光时终止手术,弱/无荧光时要求术中组织学检查。强荧光组与弱/无荧光组的诊断率相当(98% vs 100%,P=1.000),强荧光组手术时间显著更短(41 vs 77分钟,P<.001)且活检样本数更少(3.6 vs 4.9,P=.011),围手术期并发症无显著差异(7% vs 18%,P=.166)。
要点
- 强荧光活检样本可省略术中病理,诊断率与弱/无荧光需术中病理者相当。
- 强荧光组手术时间更短、活检样本数更少,围手术期并发症无显著增加。
- 弱/无荧光时应行术中组织学检查以明确诊断。
核心结论
- 5-ALA辅助的立体定向脑肿瘤活检新策略具有临床获益,可提高该标准神经外科手术的效率。
研究设计与样本
- 纳入79例在立体定向活检前接受5-ALA的疑似脑肿瘤患者,比较强荧光组与弱/无荧光组的临床指标。
主要发现
- 强荧光62例(79%),弱荧光4例(5%),无荧光13例(16%)。
- 强荧光无术中病理与弱/无荧光有术中病理的诊断率相当(98% vs 100%;P=1.000)。
- 强荧光组手术时间显著短于弱/无荧光组(41 vs 77分钟;P<.001)。
- 强荧光组平均活检样本数显著少于弱/无荧光组(3.6 vs 4.9;P=.011)。
- 强荧光组与弱/无荧光组的围手术期并发症无统计学显著差异(7% vs 18%;P=.166)。
关键数值与推荐
- 强荧光活检样本时终止手术,不要求术中组织学检查。
- 弱/无荧光时要求术中组织学检查。
临床怎么用
- 对5-ALA强荧光的立体定向脑肿瘤活检样本可省略术中病理,以缩短手术时间并减少活检样本数。
- 对弱/无荧光样本应行术中组织学检查以辅助诊断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intraoperative histopathology and acquisition of multiple tissue samples in stereotactic biopsies results in a prolonged length of surgery and potentially increased complication rate. OBJECTIVE: To investigate the clinical benefits of a novel strategy for stereotactic brain tumor biopsies with the assistance of 5-aminolevulinic acid (5-ALA) induced fluorescence. METHODS: Patients that received 5-ALA prior to stereotactic biopsy of a suspected brain tumor were included. According to our strategy, the procedure was terminated in the case of strong fluorescence of the biopsy samples. In contrast, intraoperative histology was demanded in the case of vague/no fluorescence. Length of surgery, number of biopsy samples, diagnostic rate, and periprocedural complications were compared between these 2 groups. RESULTS: Altogether, 79 patients were included, and strong fluorescence was present in 62 cases (79%), vague fluorescence was in 4 cases (5%), and no fluorescence was in 13 cases (16%). The diagnostic rate was comparable in biopsies with strong fluorescence without intraoperative histopathology and cases with vague/no fluorescence with intraoperative histopathology (98% vs 100%; P = 1.000). A significantly shorter length of surgery (41 vs 77 min; P < .001) and reduced average number of biopsy samples (3.6 vs 4.9; P = .011) was found in patients with strong compared to vague/no fluorescence. However, no statically significant difference in periprocedural complications between cases with strong and vague/no fluorescence was found (7% vs 18%; P = .166). CONCLUSION: Our data demonstrate the clinical benefits of a novel strategy for stereotactic brain tumor biopsies with assistance of 5-ALA. Thus, this biopsy strategy will increase the efficiency of this standard neurosurgical procedure in the future.
引用
- Millesi M, Kiesel B, Wöhrer A, et al. Is Intraoperative Pathology Needed if 5-Aminolevulinic-Acid-Induced Tissue Fluorescence Is Found in Stereotactic Brain Tumor Biopsy? Neurosurgery. 2020. PMID: 31049574. doi:10.1093/neuros/nyz086
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。